Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


11.12.2017

7 Aliment Pharmacol Ther
2 Am J Gastroenterol
1 Dig Dis
3 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
2 J Clin Gastroenterol
5 J Crohns Colitis
4 PLoS One
1 Scand J Gastroenterol
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. PAPAMICHAEL K, Rakowsky S, Rivera C, Cheifetz AS, et al
    Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis.
    Aliment Pharmacol Ther. 2017 Dec 6. doi: 10.1111/apt.14458.
    PubMed     Text format     Abstract available

  2. SCHMITZ EMH, Boekema PJ, Straathof JWA, van Renswouw DC, et al
    Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study.
    Aliment Pharmacol Ther. 2017 Dec 5. doi: 10.1111/apt.14453.
    PubMed     Text format     Abstract available

  3. LU MJ, Qiu XY, Mao XQ, Li XT, et al
    Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2017 Dec 4. doi: 10.1111/apt.14436.
    PubMed     Text format     Abstract available

  4. BONOVAS S, Lytras T, Nikolopoulos G, Peyrin-Biroulet L, et al
    Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis.
    Aliment Pharmacol Ther. 2017 Dec 4. doi: 10.1111/apt.14449.
    PubMed     Text format     Abstract available

  5. SINGH S, Fumery M, Sandborn WJ, Murad MH, et al
    Systematic review and network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis.
    Aliment Pharmacol Ther. 2017 Dec 4. doi: 10.1111/apt.14422.
    PubMed     Text format     Abstract available

  6. WARD MG, Warner B, Unsworth N, Chuah SW, et al
    Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.
    Aliment Pharmacol Ther. 2017;46:150-161.
    PubMed     Text format     Abstract available

  7. ANANTHAKRISHNAN AN, Sakuraba A, Barnes EL, Pekow J, et al
    The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.
    Aliment Pharmacol Ther. 2017;46:162-168.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  8. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed     Text format    

  9. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    Dig Dis

  10. GREUTER T, Vavricka SR, Biedermann L, Pilz J, et al
    Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis.
    Dig Dis. 2017 Dec 5. pii: 000484979. doi: 10.1159/000484979.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  11. DE BARROS KSC, Flores C, Harlacher L, Francesconi CFM, et al
    Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
    Dig Dis Sci. 2017;62:2481-2488.
    PubMed     Text format     Abstract available

  12. BELLOLIO ROTH F, Gomez J, Cerda J
    Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.
    Dig Dis Sci. 2017;62:2311-2317.
    PubMed     Text format     Abstract available

  13. SHAH A, Talley NJ, Walker M, Koloski N, et al
    Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?
    Dig Dis Sci. 2017;62:2472-2480.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  14. WALLDORF J, Brunne S, Gittinger FS, Michl P, et al
    Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patients.
    Eur J Gastroenterol Hepatol. 2017 Dec 5. doi: 10.1097/MEG.0000000000001037.
    PubMed     Text format     Abstract available


    Gastroenterology

  15. NIKOLAUS S, Schulte B, Al-Massad N, Thieme F, et al
    Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:1504-1516.
    PubMed     Text format     Abstract available

  16. LIU L, Nishihara R, Qian ZR, Tabung FK, et al
    Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
    Gastroenterology. 2017;153:1517-1530.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  17. ZHONG W, Lu X, Shi H, Zhao G, et al
    Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.
    J Clin Gastroenterol. 2017 Nov 28. doi: 10.1097/MCG.0000000000000961.
    PubMed     Text format     Abstract available

  18. TARIQ R, Law CCY, Khanna S, Murthy S, et al
    The Impact of Clostridium difficile Infection on Mortality in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2017 Dec 4. doi: 10.1097/MCG.0000000000000968.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  19. SMIDS C, Horjus Talabur Horje CS, Drylewicz J, Roosenboom B, et al
    Intestinal T cell profiling in Inflammatory Bowel Disease; linking T cell subsets to disease activity and disease course.
    J Crohns Colitis. 2017 Dec 4. pii: 4689802. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. KIM AH, Roberts C, Feagan BG, Banerjee R, et al
    Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus.
    J Crohns Colitis. 2017 Dec 5. pii: 4694039. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. SARLOS P, Szemes K, Hegyi P, Garami A, et al
    Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease. A meta-analysis.
    J Crohns Colitis. 2017 Dec 6. pii: 4694102. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. ALAMEEL T, Mosli MH
    Combination therapy with adalimumab and thiopurines in inflammatory bowel disease. Is it a case of nepotism in pharmacology?
    J Crohns Colitis. 2017 Dec 6. pii: 4694420. doi: 10.1093.
    PubMed     Text format    

  23. ONOUFRIADIS A, Stone K, Katsiamides A, Amar A, et al
    Exome sequencing and genotyping identify a rare variant in NLRP7 gene associated with ulcerative colitis.
    J Crohns Colitis. 2017 Dec 4. pii: 4689794. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  24. WILLIAMS AD, Korolkova OY, Sakwe AM, Geiger TM, et al
    Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    PLoS One. 2017;12:e0189551.
    PubMed     Text format     Abstract available

  25. LIN WC, Chang CW, Chen MJ, Chu CH, et al
    Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis.
    PLoS One. 2017;12:e0189377.
    PubMed     Text format     Abstract available

  26. SEKIZUKA T, Ogasawara Y, Ohkusa T, Kuroda M, et al
    Characterization of Fusobacterium varium Fv113-g1 isolated from a patient with ulcerative colitis based on complete genome sequence and transcriptome analysis.
    PLoS One. 2017;12:e0189319.
    PubMed     Text format     Abstract available

  27. HOLTMAN GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, et al
    Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.
    PLoS One. 2017;12:e0189111.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  28. LIMKETKAI BN, Sepulveda R, Hing T, Shah ND, et al
    Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease.
    Scand J Gastroenterol. 2017 Dec 7:1-5. doi: 10.1080/00365521.2017.1409364.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  29. MOGL MT, Baumgart DC, Fischer A, Pratschke J, et al
    Immunosuppression following liver transplantation and the course of inflammatory bowel disease - a case control study.
    Z Gastroenterol. 2017 Dec 6. doi: 10.1055/s-0043-117183.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: